FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. FARXIGA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Farxiga Dapagliflozin Prescribing Information Az Medical Information
FARXIGA is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure NYHA class II-IV with reduced ejection fraction.
Farxiga prescribing information. FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Please read US Full Prescribing Information and Medication Guide for FARXIGA. FULL PRESCRIBING INFORMATION.
Please read US Full Prescribing Information and Medication Guide for FARXIGA. To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure NYHA class II-IV with reduced ejection fraction to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular CV disease or multiple CV risk factors. FARXIGA dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control.
11 Limitation of Use FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. 1 INDICATIONS AND USAGE 11 Type 2 Diabetes Mellitus. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE.
FARXIGA dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control. INDICATIONS AND USAGE. FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE FARXIGA dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see Clinical Studies 14.
In patients tolerating FARXIGA 5 mg once daily who require additional glycemic. FARXIGA is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure NYHA class II-IV with reduced ejection fraction. 2 DOSAGE AND ADMINISTRATION.
As an adjunct to diet and exercise to improve glycemic control in adults with. Outside of these hours and on holidays an after-hours service is available to assist you with any urgent medical issues. Forxiga is a medicine used in adults for treating.
FARXIGA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. FARXIGA dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Dehydration the loss of body water and salt which may cause you to feel dizzy faint lightheaded or weak especially when you stand up orthostatic hypotension.
Type 2 diabetes mellitus. 13 Limitations of Use FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. 1 INDICATIONS AND USAGE.
FARXIGA dapagliflozin is indicated. In type 2 diabetes it is used with appropriate diet and exercise in patients who cannot take metformin another diabetes medicine. If you are in the US and would like additional information regarding AstraZeneca drugs please contact the Information Center at AstraZeneca at 800-236-9933 800-236-9933.
FARXIGA is not recommended for patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. FULL PRESCRIBING INFORMATION 1. Monday to Friday 8 AM to 8 PM ET excluding holidays.
FARXIGA is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure NYHA class II-IV with reduced ejection fraction. There have been reports of sudden kidney injury in people with type 2 diabetes who are taking FARXIGA. FARXIGA may cause serious side effects including.
Heart Failure Medication for Adults FARXIGA dapagliflozin. Type 2 Diabetes Mellitus To improve glycemic control the recommended starting dose of FARXIGA is 5 mg orally once daily taken in the morning with or without food. It can also be used as add-on treatment to other diabetes medicines.
To reduce the risk of hospitalization for heart failure in adults with type 2 diabetes. Diabetes in patients whose condition is not controlled well enough.
